IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 123 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,198,795 | -10.2% | 42,366 | +3.7% | 0.00% | – |
| Q2 2023 | $2,449,606 | +26.5% | 40,854 | +4.3% | 0.00% | – |
| Q1 2023 | $1,936,367 | -53.2% | 39,166 | -45.9% | 0.00% | – |
| Q4 2022 | $4,135,292 | +884.6% | 72,460 | +709.5% | 0.00% | – |
| Q3 2022 | $420,000 | -5.0% | 8,951 | -24.4% | 0.00% | – |
| Q2 2022 | $442,000 | +104.6% | 11,834 | +87.4% | 0.00% | – |
| Q4 2021 | $216,000 | -6.1% | 6,316 | +1.9% | 0.00% | – |
| Q3 2021 | $230,000 | – | 6,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $17,200,000 | 9.25% |
| Velan Capital Investment Management LP | 293,385 | $8,772,000 | 8.14% |
| Paradigm Biocapital Advisors LP | 499,190 | $14,926,000 | 3.95% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $11,529,000 | 2.31% |
| Rock Springs Capital Management LP | 2,552,034 | $76,306,000 | 1.92% |
| Samsara BioCapital, LLC | 160,963 | $4,813,000 | 1.21% |
| RTW INVESTMENTS, LP | 1,859,471 | $55,598,000 | 1.15% |
| Pier Capital, LLC | 236,616 | $7,075,000 | 0.90% |
| Avidity Partners Management LP | 1,363,800 | $40,778,000 | 0.85% |
| Rhenman & Partners Asset Management AB | 170,472 | $5,097,000 | 0.50% |